Drug Eluting Balloons (DEB) Market Size, Share, Growth, And Industry Analysis, By Type (Peripheral DEBs & Coronary DEBs) By Application (Catheterization Laboratory, Hospital, Others) Regional Forecast From 2025 To 2033

• 

  Request a Free sample to learn more about this report

DRUG ELUTING BALLOONS (DEB) MARKET OVERVIEW

The global Drug Eluting Balloons (DEB) Market size is USD 0.84 billion in 2024 and is expected to reach USD 2.56 billion by 2033, growing at a compound annual growth rate (CAGR) of about 13.1% during the forecast period.

The global COVID-19 pandemic has been unprecedented and staggering, with the drug eluting balloons (DEB) Market experiencing higher-than-anticipated demand across all regions compared to pre-pandemic levels. The sudden rise in CAGR is attributable to the market's growth and demand returning to pre-pandemic levels once the pandemic is over.

Drug-eluting balloons (DEBs) are medical devices used in the field of interventional cardiology and vascular surgery. They are a type of angioplasty balloon catheter that combines traditional balloon angioplasty with the controlled release of a drug directly to the vessel wall. The main purpose of a drug-eluting balloon is to treat the narrowing or blockage of blood vessels caused by atherosclerosis, which is the build-up of fatty deposits (plaque) on the inner walls of arteries. This narrowing restricts blood flow and can lead to various cardiovascular problems, including heart attacks and strokes.

The drug-eluting balloons (DEB) market was experiencing significant growth and was expected to continue expanding in the coming years. The DEB market has witnessed competition among several medical device manufacturers, with many companies investing in research and development to introduce novel DEB products and expand their market presence.

COVID-19 IMPACT

Market Faced a Decline in Demand Due to Delayed Elective Procedures During the Pandemic

There was no single sector unaffected by COVID-19. Drug Eluting Balloons (DEB) Market was affected as well. During the peak of the pandemic, many hospitals and healthcare facilities were overwhelmed with COVID-19 cases, and elective procedures, including those involving DEBs, were often postponed or canceled. This led to a temporary decline in DEB procedures and impacted the revenues of medical device manufacturers and healthcare providers.

LATEST TRENDS

Expanding Indications to Provide More Benefits to the Consumers of the Market

The Drug Eluting Balloons (DEB) Market is as dynamic as any market. In the market, there is everyday development in the market to add more benefits to it. Recently, in the market, in which initially, DEBs were primarily used in coronary artery disease and peripheral artery disease. However, there has been a growing interest in exploring their use in other vascular territories and indications, such as in the treatment of arteriovenous fistulas in dialysis patients.

Request a Free sample to learn more about this report

DRUG ELUTING BALLOONS (DEB) MARKET SEGMENTATION

By Type Analysis

According to type, the market can be segmented into Peripheral DEBs & Coronary DEBs

In terms of services, Double Channel is the largest segment, as it holds the maximum share of the market.

By Application Analysis

Based on application, the market can be divided into Catheterization Laboratory, Hospital, & Others.

DRIVING FACTORS

Continuous Research and Advancements Have Increased Demand in the Market

Ongoing research and development efforts have led to improvements in DEB technology, including better drug coatings, optimized drug release profiles, and enhanced balloon designs. These technological advancements contribute to improved treatment outcomes and patient experiences. Researchers are continuously working to develop more effective drug coatings for DEBs, which can lead to enhanced therapeutic outcomes and reduced rates of restenosis. The development of combination devices that integrate DEBs with other technologies, such as drug-eluting stents or scaffolds, offers new treatment options and can drive market growth. 

Prevalence of Cardiovascular Diseases Have Influenced the Demand in the Market

The increasing incidence of cardiovascular diseases, such as coronary artery disease and peripheral artery disease, is a major driver of the DEB market. DEBs are used to treat arterial blockages in these conditions, and the rising prevalence of these diseases contributes to the demand for effective treatment options.  Many patients prefer minimally invasive treatments that offer faster recovery times and fewer complications. DEBs align with these preferences and contribute to patient satisfaction. This contributes to the Drug Eluting Balloons (DEB) Market growth.  

RESTRAINNG FACTORS

Restenosis and Revascularization Rates Could Lead to a Declining Trend in the Market 

Despite the use of drug-eluting balloons, some patients may still experience restenosis (re-narrowing of the treated artery) or require revascularization procedures in the future. These outcomes could impact the perception and adoption of DEBs in certain cases. As a consequence, there can be a declining trend in the market. 

• Request a Free sample to learn more about this report

•  

DRUG ELUTING BALLOONS (DEB) MARKET REGIONAL INSIGHTS

North America Region Dominates the Market as it has Advanced Healthcare Infrastructure

North America has the largest Drug Eluting Balloons (DEB) Market share as it boasts a well-developed and advanced healthcare infrastructure, with state-of-the-art medical facilities and a high level of access to medical technologies. This allows for the early adoption and availability of cutting-edge medical devices like DEBs. Cardiovascular diseases, such as coronary artery disease and peripheral artery disease, are prevalent in North America due to factors like sedentary lifestyles, unhealthy diets, and an aging population. The high incidence of these conditions drives the demand for effective treatments like DEBs. The United States has a robust regulatory system for medical devices through the U.S. Food and Drug Administration (FDA). Timely and efficient approvals of new DEBs and expanded indications contribute to a more extensive product portfolio and market presence. North America has well-established healthcare education and awareness programs that educate physicians and patients about the benefits of DEBs in treating cardiovascular diseases. Increased awareness leads to higher demand for these devices.

KEY INDUSTRY PLAYERS

Key Players Focus On Research and Development & Innovation for Marketing and Spreading Awareness

Key players invest heavily in research and development to improve existing DEB technology and develop new and advanced DEB products. They conduct clinical studies to evaluate the safety and efficacy of their DEBs and gather clinical evidence to support regulatory approvals and market adoption. Innovation is crucial in the medical device industry, and key players invest in research to develop novel technologies and secure patents to protect their intellectual property. Key players formulate business strategies to expand their market presence, which may include acquisitions, partnerships, collaborations, and geographic expansions. Key players invest in marketing and awareness campaigns to promote their DEB products and create awareness among patients and healthcare providers about the benefits of DEBs in treating cardiovascular diseases. 

List of Top Drug Eluting Balloons (DEB) Companies

• B. Braun(Germany)
• Medtronic(Ireland)
• Boston Scientific (United States)
• BD (United States)
• Yinyi (United States)
• Philips
• Eurocor
• Aachen Resonance
• Biotronic

REPORT COVERAGE

The report brings together extensive research on the qualitative and quantitative factors affecting the market. It gives an overall macro and micro view of the online reputation service industry. This research profiles a report with extensive studies on the online reputation management services market that describe the firms affecting the forecasting period. Detailed studies also offer a comprehensive analysis by inspecting factors like segmentation, opportunities, industrial developments, trends, growth, size, share, restraints, etc.

Furthermore, the post-COVID-19 pandemic’s effect on international market restrictions and a deep understanding of how the industry will recover and strategies are also stated in the report. Finally, the competitive landscape has also been examined in detail to provide clarification of the competitive landscape.